Table 1.
Therapeutic agents | Reported effect | Observed effect | Conc tested* | Non-toxic conc used |
---|---|---|---|---|
Flurbiprofen | Self-renewal | Self-renewal | 10uM-1mM | 50uM |
Gatifoxacin | Self-renewal | Self-renewal | 10uM-1mM | 5uM |
Sinomenine | Self-renewal | Differentiation | 10uM-1mM | 50uM |
Theanine | Self-renewal | Differentiation | 10uM-1mM | 10uM |
Digitoxin | Differentiation | Differentiation | 100pM-10nM | 5nM |
Digoxin | Differentiation | Differentiation | 100pM-10nM | 1nM |
Cymarin | Differentiation | Differentiation | 10pM-1nM | 1nM |
Selegiline | Differentiation | Differentiation | 10uM-1mM | 100uM |
Retinoic Acid** | Differentiation | Differentiation | 100nM-10uM | 1uM |
10uM concentrations used by Desbordes et al., 2008;
Positive control for differentiation